Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Zenas BioPharma, Inc(ZBIO) | 0 | 4,911,539 | +4,911,539 | 0 | 83,103 | 16.66% | +83,103 |
| Arcellx, Inc. COMMON STOCK | 2,346,630 | 2,346,630 | 0 | 129,511 | 195,967 | 39.29% | +66,457 |
| ARS Pharmaceuticals, Inc.(SPRY) | 4,012,903 | 4,012,903 | 0 | 34,150 | 58,187 | 11.67% | +24,037 |
| Design Therapeutics, Inc.(DSGN) | 6,526,476 | 6,526,476 | 0 | 21,864 | 35,112 | 7.04% | +13,249 |
| Oruka Therapeutics, Inc(ORKA) | 0 | 375,330 | +375,330 | 0 | 9,199 | 1.84% | +9,199 |
| Mineralys Therapeutics Inc.(MLYS) | 2,016,822 | 2,016,822 | 0 | 23,597 | 24,424 | 4.90% | +827 |
| enGene Holdings Inc. COM | 500,000 | 747,750 | +247,750 | 4,715 | 4,935 | 0.99% | +220 |
| KALA Bio, Inc.(KALA) | 443,661 | 443,661 | 0 | 3,146 | 2,529 | 0.51% | -617 |
| Nkarta, Inc.(NKTX) | 3,333,333 | 3,333,333 | 0 | 19,700 | 15,067 | 3.02% | -4,633 |
| Alumis Inc. | 1,959,896 | 1,959,896 | 0 | 26,067 | 20,932 | 4.20% | -5,135 |
| CRISPR Therapeutics AG(CRSP) | 1,048,951 | 1,048,951 | 0 | 56,654 | 49,280 | 9.88% | -7,374 |